Related Experiment Videos
Early onset parkinsonism in Chinese
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|October 1, 1991
Summary
This study details parkinsonism in young adults, finding all patients responded to levodopa. However, long-term treatment led to dyskinesia in most young-onset Parkinson's disease and juvenile parkinsonism patients.
Area of Science:
- Neurology
- Movement Disorders
- Clinical Neuroscience
Background:
- Parkinsonism in individuals under 40 presents unique clinical challenges.
- Distinguishing between young-onset Parkinson's disease (YOPD) and juvenile parkinsonism (JP) is crucial for understanding disease progression.
- Early-onset parkinsonism requires comprehensive characterization of symptoms and treatment responses.
Purpose of the Study:
- To describe the clinical features of parkinsonism in patients under 40 years of age.
- To analyze the response to levodopa therapy and the incidence of dyskinesia in YOPD and JP.
- To investigate potential correlations between disease duration, treatment, and adverse effects.
Main Methods:
- Retrospective analysis of 25 patients with parkinsonism onset before age 40.
- Classification into YOPD (onset >21 years) and JP (onset <21 years).
- Detailed recording of clinical symptoms, sensory complaints, dystonia, diurnal fluctuations, familial history, levodopa response, and dyskinesia development.
Main Results:
- All 25 patients exhibited rigidity and akinesia; resting tremor was infrequent.
- Aching leg sensation preceded parkinsonian features in 32% of cases.
- Levodopa therapy yielded dramatic symptomatic improvement in all patients.
- Dyskinesia developed in 100% of YOPD and 83% of JP patients with extended levodopa treatment, correlating positively with treatment duration.
Conclusions:
- Parkinsonism with onset before 40 years, including YOPD and JP, responds well to levodopa.
- Long-term levodopa use is associated with a high cumulative incidence of dyskinesia in both YOPD and JP.
- The development of dyskinesia necessitates careful consideration of treatment duration and potential alternatives in managing early-onset parkinsonism.